The polymorphism of DOPA decarboxylase (DDC), which can catalyze the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, affects the L-DOPA response in patients with PD (Devos et al., 2014). This evidence concerns the gene DDC and Parkinson disease.